FDA Drug Recalls

Recalls / Class II

Class IID-0339-2025

Product

Rosuvastatin Tablets 40mg, 30-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-264-30

Brand name
Rosuvastatin Calcium
Generic name
Rosuvastatin Calcium
Active ingredient
Rosuvastatin Calcium
Route
Oral
NDCs
68462-261, 68462-262, 68462-263, 68462-264
FDA application
ANDA079172
Affected lot / code info
Lot # 17240389, exp. date Feb-26 17240390, exp. date Feb-26 17240426, exp. date Feb-26 17240427, exp. date Feb-26 17240428, exp. date Feb-26 17240778, exp. date Apr-26 17241055, exp. date May-26 17241074, exp. date Jun-26 17241075, exp. date Jun-26 17241091, exp. date Jun-26 17241100, exp. date Jun-26

Why it was recalled

CGMP Deviations

Recalling firm

Firm
Glenmark Pharmaceuticals Inc., USA
Manufacturer
Glenmark Pharmaceutials Inc., USA
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
750 Corporate Dr, N/A, Mahwah, New Jersey 07430-2009

Distribution

Quantity
N/A
Distribution pattern
U.S. Nationwide

Timeline

Recall initiated
2025-03-13
FDA classified
2025-04-08
Posted by FDA
2025-04-16
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0339-2025. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.